(Q39467317)

12 September 2017

Surveillance of cryptococcosis in Alabama, 1992-1994. (English)

1 reference

12 September 2017

0 references

1 reference

Thomas CJ

1

1 reference

12 September 2017

Lee JY

2

1 reference

12 September 2017

Conn LA

3

1 reference

12 September 2017

Bradley ME

4

1 reference

12 September 2017

Gillespie RW

5

1 reference

12 September 2017

Dill SR

6

1 reference

12 September 2017

Pinner RW

7

1 reference

12 September 2017

Pappas PG

8

1 reference

12 September 2017

1 May 1998

1 reference

12 September 2017

Annals of Epidemiology

1 reference

12 September 2017

8

1 reference

12 September 2017

212-216

1 reference

12 September 2017

4

1 reference

Fungal infections in cancer patients: an international autopsy survey.

12 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2897%2900234-2

7 January 2021

Cryptococcosis in a renal unit

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2897%2900234-2

7 January 2021

Cryptococcal meningitis in patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2897%2900234-2

7 January 2021

Cryptococcosis in the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2897%2900234-2

7 January 2021

Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2897%2900234-2

7 January 2021

Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2897%2900234-2

7 January 2021

Cryptococcal infections in patients with acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2897%2900234-2

7 January 2021

A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2897%2900234-2

7 January 2021

DIAGNOSTIC AND PROGNOSTIC VALUE OF CLINICAL AND LABORATORY FINDINGS IN CRYPTOCOCCAL MENINGITIS, A FOLLOW-UP STUDY OF FORTY PATIENTS

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2897%2900234-2

7 January 2021

The wide spectrum of cryptococcal infections

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2897%2900234-2

7 January 2021

Amphotericin B in cryptococcal meningitis. Long-term results of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2897%2900234-2

7 January 2021

Torulosis of the central nervous system; review of literature and report of 5 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2897%2900234-2

7 January 2021

Epidemiology of HIV infection and AIDS in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2897%2900234-2

7 January 2021

Emergence of cryptococcal disease: epidemiologic perspectives 100 years after its discovery

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2897%2900234-2

7 January 2021

Molecular subtype distribution of Cryptococcus neoformans in four areas of the United States. Cryptococcal Disease Active Surveillance Group

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2897%2900234-2

7 January 2021

Estimation of the prevalence of cryptococcal infection among patients infected with the human immunodeficiency virus in New York City

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2897%2900234-2

7 January 2021

Aspergillosis and other systemic mycoses. The growing problem

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2897%2900234-2

7 January 2021

Clinical epidemiological study of 171 cases of cryptococcosis

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2897%2900234-2

7 January 2021

A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2897%2900234-2

7 January 2021

Primary prophylaxis against opportunistic infections in patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2897%2900234-2

7 January 2021

Prophylaxis for opportunistic infections in patients with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2897%2900234-2

7 January 2021

Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2897%2900234-2

7 January 2021

10.1016/S1047-2797(97)00234-2

Identifiers

DOI

1 reference

12 September 2017

1 reference